Silobreaker.com    Log In
   My Page    Help   
360° SearchNetworkHot SpotsTrends
 
Advanced Search Options >>
Saturday, November 21, 2009 10:17 PM

Published 10/29/2009 by Nasdaq


Europe Regulators Report 4 PML Deaths On Tysabri Since '06

NEW YORK -(Dow Jones)- European regulators reported four deaths from a rare brain infection in multiple sclerosis patients taking Tysabri, sold by Biogen Idec Inc. (BIIB) and Elan Corp. PLC (ELN), since its 2006 relaunch.

One other death had been reported in a Tysabri patient since it was removed...

Share this 

What others report on the same story

UPDATE 1-EU agency reports 24th case of Tysabri... - [10/29/2009 - Reuters UK]
Weighing Future Paths for Biogen's Tysabri - [10/29/2009 - Morningstar.ca]
Four deaths linked to MS drug Tysabri, say auth... - [10/30/2009 - Drogheda Independent]
1

Quotes

...the agency is "still receiving and reviewing follow-up information on cases of PML, so we cannot yet comment further."
Europe Regulators Report 4 PML Deaths On Tysabri Since '06 [Nasdaq - 10/29/2009]
"For a disease which previously had an extremely high mortality rate, an 83% rate of survival is outstanding" he wrote in a note...
Europe Regulators Report 4 PML Deaths On Tysabri Since '06 [Nasdaq - 10/29/2009]

Related Stories

First Reported 10/23/2009 - Updated 10/24/2009 - 14 Documents (in Health)
Elan shares fall by 20pc as drug-linked disease cases rise
Shares in Elan plunged 20pc to ?3.42 in Dublin yesterday after its multiple sclerosis treatment Tysabri was linked to over 20 cases of a potentially fatal brain disease and the European drug watchdog said it was reviewing its use. Elan finished at ?3.42 ... [Irish Independent - 10/24/2009]
First Reported 10/22/2009 - Updated 10/22/2009 - 1 Documents (in Biology)
Johnson & Johnson - Click to view image in its original context
Johnson & Johnson
Elan focuses on boosting MS drug sales after selling stake to J&J
Kelly Martin, chief executive of Elan, said the Irish drugs group would focus on increasing sales of its multiple sclerosis drug Tysabri, following the sale of a stake... ... [FT.com - Health - 10/22/2009]
In Focus
Network

Blogs

sort by: Date | Relevance
Europe, the U.S., and breaking up the banks [Dealscape - 11/03/2009]
With the recovery at least beginning, European and now British regulators are clearly leaning toward a more competitive banking system with smaller players. ...
Europe, the U.S., and breaking up the banks [The Deal.com - 11/03/2009]
With the recovery at least beginning, European and now British regulators are clearly leaning toward a more competitive banking system with smaller players. ...
Europe getting 'Internet freedom' law [CNET News.com - 11/05/2009]
A major overhaul of telecommunications regulations tackles issues ranging from data-breach notification to faster number porting to "three strikes" for file sha ...
Study on Social Media Use in Europe [FOLDEN eMarketing Blog - 10/23/2009]
The European Commission has released a study on social media use and user generated content in Europe. The study is giving an overview about the market in Europe ...
Europe does not need a big shot [Gideon Rachman's Blog - 10/27/2009]
Poor Tony Blair – sabotaged by his own countryman. Just weeks ago,Mr Blair looked like the frontrunner to be president of the European Union. But now William Hague, ...
1 2 3 4 5 6 7 8 9 10 ...

Audio/Video

sort by: Date | Relevance
David Cameron: A policy on Europe that people c... [The Conservative Party (UK) - YouTube Channel - 11/04/2009]
Europe Shocked GM to Keep Opel [Associated Press - YouTube - 11/04/2009]
Does CIA torture? Evidence of alleged secret ja... [Russia Today - YouTube - 11/05/2009]
Pushing for biotech-based crops in Europe [Mefeedia Video Tag : biotechnolo - 10/22/2009]
Get the facts : Patient-centred healthcare syst... [EuropaBio - YouTube - 11/03/2009]
1 2

  •  
  •  
  •